ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA
Not Applicable
- Registration Number
- CTRI/2020/04/024784
- Lead Sponsor
- Dr Sameer Malhotra SELF SPONSORED NO CONFLICT OF INTEREST
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants of the age of 18 years and above
Participants residing in India
Participants with minimum 10 years of education with basic knowledge of English
Exclusion Criteria
Participants under the age of 18 years
Participants residing outside of IndiaÂ
Participants with previous history of any major psychiatric illness, psychiatric hospitalization or currently on any psychiatric medication.Â
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7) and Patient Health Questionnaire (PHQ-9). Rise in Anxiety and Depression will be noted. <br/ ><br>Timepoint: 1 month during the period of COVID-19 pandemic. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Through the analysis of the results, it will help device psychological intervention/mental health programs geared towards general and specific symptoms and management of emotional needs can be provided to the general population during and post-crisis.Timepoint: 1 month during the period of COVID-19 pandemic.